Nanoparticle-Induced Breast Cancer Cell Death: The Associated Mechanisms of Seven Major Cell Death Pathways in

Shirui Wang1,2, Cuicui Chang1,2, Rui Xu1,2

  • 1Main Campus, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China.

Cells
|April 13, 2026
PubMed

Insights

Nanoparticles offer a promising new approach to breast cancer treatment by triggering various cell death mechanisms. This review details how nanoparticles induce cell death in breast cancer, aiding future nanotechnology applications.

Area of Science:

  • Oncology
  • Nanotechnology
  • Molecular Biology

Background:

  • Breast cancer remains a significant global health challenge due to its complexity and treatment resistance.
  • Nanoparticles are emerging as a novel therapeutic strategy for breast cancer, leveraging their unique properties for targeted delivery and enhanced efficacy.
  • Nanoparticle administration has been shown to activate multiple programmed cell death pathways, including apoptosis, pyroptosis, and ferroptosis.

Purpose of the Study:

  • To review the molecular mechanisms of nanoparticle-induced cell death in breast cancer models.
  • To explore the potential of nanotechnology for precise breast cancer treatment.
  • To provide a framework for future research on nanoparticle-mediated cancer therapy.

Main Methods:

  • Systematic review of recent scientific literature on nanoparticles and breast cancer cell death.
  • Analysis of molecular pathways involved in apoptosis, pyroptosis, necroptosis, autophagy, ferroptosis, cuproptosis, and disulfidptosis induced by nanoparticles.
  • Focus on studies utilizing breast cancer models.

Main Results:

  • Nanoparticles effectively induce diverse cell death mechanisms in breast cancer cells.
  • The observed cell death pathways are potentially applicable to other solid tumors, indicating a universal response.
  • Nanoparticle properties facilitate increased anticancer activity through targeted cell death induction.

Conclusions:

  • Nanoparticle-mediated cell death pathways represent a promising avenue for advanced breast cancer therapies.
  • Understanding these mechanisms is crucial for the translational application of nanotechnology in oncology.
  • This review provides a foundation for further investigation into nanoparticle-induced cell death across various cancer types.